Microvision (MVIS) 3.20 $MVIS Most active Nasdaq-traded

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2015 at 2:07 PM

Microvision (MVIS) 3.20 $MVIS

Most active Nasdaq-traded stocks
AP - 47 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 28.34 (-0.38), MVIS: 3.20 (+0.46), FB: 77.64 (-0.41), SLXP: 172.80 (+3.40), MSFT: 41.40 (+0.02), INTC: 30.80 (-0.13), AAPL: 124.24 (+0.65), CSCO: 28.30 (+0.36)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - 1 hr 21 mins ago

SCON: 1.38 (-0.19), NES: 2.67 (-0.25), ADXS: 14.02 (+1.61), PRTS: 2.20 (-0.37), PFIE: 1.38 (-0.42), MVIS: 3.20 (+0.46), NSLP: 5.25 (-1.16), TRIL: 17.79 (+2.14), VRML: 1.77 (+0.10), DSKY: 7.69 (-3.13), STRL: 3.49 (+0.49), INO: 8.27 (+1.23), ENZ: 2.80 (-0.51), ICEL: 8.71 (+1.08), MTL: 1.10 (-0.44), MSO: 6.29 (+0.73), HELI: 1.45 (-0.20), PKOH: 47.92 (-8.22), OGEN: 1.45 (+0.25), BLPH: 10.97 (+1.22)

MicroVision (MVIS) Stock Is Up Today After Receiving Component Order
at The Street - Mon Mar 16, 9:01AM CDT
MicroVision (MVIS) is gaining Monday after receiving a $14.5 million in component orders.
MVIS: 3.20 (+0.46)

MicroVision +16.1%; $14.5M worth of component orders received
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 8:16AM CDT

MVIS: 3.20 (+0.46)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 8:14AM CDT

KNDI: 14.47 (+1.24), WLL: 38.37 (-1.63), ADXS: 14.02 (+1.61), LTM: 70.62 (+3.42), MVIS: 3.20 (+0.46), AMRN: 3.00 (+0.10), MTL: 1.10 (-0.44), FXCM: 2.39 (-0.19), CTIC: 2.00 (+0.03), DSKY: 7.69 (-3.13)

MicroVision +3.6% after Q4 report; backlog rises to $5.1M
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 12:19PM CDT

MVIS: 3.20 (+0.46)

MicroVision's (MVIS) CEO Alexander Tokman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 10, 10:21AM CDT

MVIS: 3.20 (+0.46)

Microvision (MVIS) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Mar 10, 7:25AM CDT

MVIS: 3.20 (+0.46)

Microvision EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 7:03AM CDT

MVIS: 3.20 (+0.46)

MicroVision Announces 2014 Operating Results with Strong Momentum Heading Into 2015
Business Wire - Tue Mar 10, 7:00AM CDT
MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display technology, today announced its 2014 operating and financial results and an overview of its 2015 business objectives.
MVIS: 3.20 (+0.46)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Mar 09, 4:30PM CDT

BPI: 9.45 (-0.10), TCPC: 16.13 (-0.04), MVIS: 3.20 (+0.46), JW.A: 60.59 (+0.50), BKS: 23.50 (-0.07), YORW: 23.37 (-0.28), SUP: 18.74 (-0.13), LINC: 2.77 (-0.01), LMIA: 12.25 (-0.12)

Apple Falls on Possible Watch Impact, Amazon Rises on Store Opening: Tech Winners & Losers
at The Street - Thu Mar 05, 4:34PM CST
Apple tumbles after an analyst questions the ability of Apple Watch to have a substantial effect on the company's revenue. Amazon jumps after opening a store on an Alibaba site.
AMZN: 372.61 (+2.03), MVIS: 3.20 (+0.46), AAPL: 124.24 (+0.65)

MicroVision +11%; PicoP licensed to Fortune 100 partner
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 9:29AM CST

MVIS: 3.20 (+0.46)

Global Automotive Head-up Display (HUD) Market for Luxury & Premium Cars 2014-2019
M2 - Mon Jan 19, 10:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/2fvqvd/automotive) has announced the addition of the "Automotive Head-up Display (HUD) Market by HUD type, Application and Geography - Industry Trends and Forecast to 2019" report to their offering. The global automotive HUD market for Luxury & Premium car size, in terms of value, is estimated to be at $146.2 million in 2014, which is projected to grow to $252.6 million by 2019, at a CAGR of 11.52%. Road accidents occur either due to poor quality of road transport system or a break in the balance between the environmental demand and the driver's ability to act. It is a man-made crisis, with human error responsible for over 90% of accidents. In an attempt to counter the growing number of road accidents, the auto industry has begun to adopt safety equipment in a big way. As automakers introduce advanced driver assistance systems (ADAS), digital instrument clusters, heads up displays, and other new technologies; consumers are demonstrating readiness to adapt to these systems. The global boom in premium and luxury cars is expected to continue. Ultra-high net worth individuals who are customers for these cars are expected to grow by 3% to 5% annually. The HUD systems are usually offered as optional equipment, and its higher cost is a major restraint for its adaptability. To achieve economies of scale, the technology should be produced for mid-segment cars which constitute to the major share of automotive sales. Prices are expected to decline, as volume grows and development costs are paid off, enabling more widespread adoption. Europe and North America are growing at a good pace, owing to the increase in luxury vehicle sales. With the increase in purchasing power and penetration of luxury cars in emerging nations such as China, Brazil, and India has resulted in an increase in demand of luxury cars. Asia-Oceania is estimated to be the largest market for HUD. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Automotive Hud Market, By Region 8 Automotive Hud Market, By Application 9 Automotive Hud Market, By Type 10 Competitive Landscape 11 Company Profiles - BMW AG - Continental AG - Delphi Automotive PLC - Denso Corporation - General Motors Company - Johnson Controls, Inc. - Microvision, Inc. - Nippon Seiki Co., Ltd. - Robert Bosch Gmbh - Visteon Corporation For more information visit http://www.researchandmarkets.com/research/2fvqvd/automotive
VC: 97.89 (-0.64), MVIS: 3.20 (+0.46), GM: 38.50 (+0.45), DLPH: 78.05 (+1.25), JCI: 49.75 (+0.93)

Microvision (MVIS) Worth a Look: Stock Adds 6.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 7:30AM CST
Microvision Inc. (MVIS) was a big mover last session, as the company saw its shares rise roughly 7% on the day.
MVIS: 3.20 (+0.46), RSTI: 23.90 (+0.19)

6 Stocks To Watch Or Buy From Consumer Electronics Show 2015
Chris Katje - at Seeking Alpha - Tue Jan 06, 3:07AM CST

ATML: 8.69 (+0.23), LPL: 14.33 (+0.54), NEON: 2.83 (+0.13), SNCR: 47.98 (+1.72), MVIS: 3.20 (+0.46), KODK: 18.02 (-0.34), ALV: 114.30 (+2.45)

Stock to Watch: Microvision Up 7.1% (MVIS)
Comtex SmarTrend(R) - Mon Jan 05, 10:06AM CST
Microvision (NASDAQ:MVIS) is one of today's best performing low-priced stocks, up 7.1% to $2.10 on 1.6x average daily volume. Thus far today, Microvision has traded 502,000 shares, vs. average volume of 308,000 shares per day. The stock has outperformed the Dow (7.1% to the Dow's -1.2%) and outperformed the S&P 500 (7.1% to the S&P's -1.3%) during today's trading.
MVIS: 3.20 (+0.46)

Will Microvision (MVIS) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 6:25AM CST
Will Microvision (MVIS) Continue to Surge Higher?
MVIS: 3.20 (+0.46)

Cutera, Inc. (CUTR) in Focus: Stock Adds 7.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 8:32AM CST
Cutera, Inc. (CUTR) was a big mover last session, as the company saw its shares rise more than 7% on the day.
MVIS: 3.20 (+0.46), CUTR: 13.74 (+0.24)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...